Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 197 citing Rayner: Relationships of upper gastrointestinal motor and sensory function with glycemic control. (0.11 sec) 

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma …

- endojournals.org
OG Kolterman, JB Buse, MS Fineman, E Gaines … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
Despite the advent of new treatments, glucose control in the type 2 diabetes
population is unsatisfactory. AC2993 (synthetic exendin-4; exenatide), a novel
glucose-dependent insulinotropic agent, exhibited notable antidiabetic ...
Cited by 275 - Related articles - BL Direct - All 6 versions

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin …

- diabetesjournals.org
MS Fineman, TA Bicsak, LZ Shen, K Taylor, E … - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—All three AC2993 regimens led to significant reductions in serum
fructosamine relative to placebo (P ≤ 0.004). Mean reductions ranged from 39
to 46 μmol/l. All AC2993 groups had reductions in HbA 1c ranging from 0.7 ...
Cited by 230 - Related articles - BL Direct - All 10 versions

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved …


LL Nielsen, AA Young, DG Parkes - Regulatory peptides, 2004 - Elsevier
Exenatide (synthetic exendin-4), glucagon-like peptide-1 (GLP-1), and GLP-1
analogues have actions with the potential to significantly improve glycemic
control in patients with diabetes. Evidence suggests that these agents use ...
Cited by 185 - Related articles - All 7 versions

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk …


L Blonde, EJ Klein, J Han, B Zhang, SM Mac, … - Diabetes, Obesity & Metabolism, 2006 - pt.wkhealth.com
Results: Patients completed 82 weeks of exenatide treatment [n = 314, 63% M, age
56 ± 10 years, weight 99 ± 21 kg, body mass index 34 ± 6 kg/m 2 , A1C 8.3 ±
1.0% (mean ± SD)]. Reduction in A1C from baseline to week 30 [-0.9 ± 0.1% ...
Cited by 172 - Related articles - BL Direct - All 6 versions

Gastric emptying in diabetes: clinical significance and treatment


M Horowitz, D O'Donovan, KL Jones, C … - Diabetic medicine, 2002 - pt.wkhealth.com
The outcome of recent studies has led to redefinition of concepts relating to
the prevalence, pathogenesis and clinical significance of disordered gastric
emptying in patients with diabetes mellitus. The use of scintigraphic ...
Cited by 150 - Related articles - BL Direct - All 8 versions

American Gastroenterological Association technical review on the diagnosis and treatment …


HP Parkman, WL Hasler, RS Fisher - Gastroenterology, 2004 - Elsevier
Normal gastric emptying reflects a coordinated effort between different regions
of the stomach and the duodenum as well as extrinsic modulation by central
nervous system (CNS) and distal gut factors. Important events related to ...
Cited by 141 - Related articles - BL Direct - All 15 versions

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 …


OG Kolterman, DD Kim, L Shen, JA Ruggles, … - American Journal of Health-System Pharmacy, 2005 - ASHP
R UGGLES , P H .D., is Associate Director Medical Writing, Medical Af- fairs; L
ORETTA L. N IELSEN , P H .D., is Senior Medical Writer, Medical Affairs; M ARK
S. F INEMAN , BS, is Senior Director, Clinical Affairs; and A LAIN D. B ...
Cited by 139 - Related articles - All 5 versions

Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1

- glucagon.com [PDF]  - Free from Publisher
MC Riddle, DJ Drucker - Diabetes Care, 2006 - Am Diabetes Assoc
Current therapies for type 2 diabetes are frequently associated with inadequate
control of postprandial hyperglycemia, weight gain, and, in the case of oral
agents, loss of efficacy over time. A better understanding of physiological ...
Cited by 71 - Related articles - BL Direct - All 10 versions

[PDF] Diabetic gastropathy and prokinetics


NJ Talley - The American journal of gastroenterology, 2003 - usagiedu.com
ABSTRACT The treatment of diabetic gastropathy, which here refers to a clinical
syndrome of upper GI tract symptoms suggestive of an upper motility disturbance
in diabetes whether or not there is delayed gastric emptying, remains ...
Cited by 71 - Related articles - View as HTML - BL Direct - All 13 versions

Autonomic peripheral neuropathy

- cchil.org [PDF] 
R Freeman - Neurologic clinics, 2007 - Elsevier
Most generalized peripheral polyneuropathies are accompanied by clinical or
subclinical autonomic dysfunction. There is a group of peripheral neuropathies
in which the small or unmyelinated fibers are selectively targeted [1]. In ...
Cited by 57 - Related articles - All 13 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google